Related Experiment Video

Updated: Aug 14, 2026

Exploring the Pharmacological Action and Molecular Mechanism of Salidroside in Inhibiting MCF-7 Cell Proliferation and Migration
11:13

Exploring the Pharmacological Action and Molecular Mechanism of Salidroside in Inhibiting MCF-7 Cell Proliferation and Migration

Published on: June 9, 2023

RNA interference-mediated choline kinase suppression in breast cancer cells induces differentiation and reduces

Kristine Glunde1, Venu Raman, Noriko Mori

  • 1John Hopkins University In Vivo Cellular Molecular Imaging Center Program, Russell H. Morgan Department of Radiology and Radiological Science, John Hopkins University School of Medicine, Baltimore, Maryland 21205, USA.

Cancer Research
|December 3, 2005
PubMed

Insights

Targeting choline kinase with RNA interference (RNAi) in breast cancer cells reduces proliferation and promotes differentiation. Noninvasive magnetic resonance spectroscopy (MRS) can monitor these effects, supporting choline kinase as a therapeutic target.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Choline kinase (ChoK) is overexpressed and activated in breast cancer, presenting a potential therapeutic target.
  • Oncogenes and mitogenic signals activate choline kinase, contributing to cancer progression.

Purpose of the Study:

  • To investigate the effects of RNA interference (RNAi)-mediated choline kinase down-regulation in human breast epithelial cells.
  • To evaluate the utility of magnetic resonance spectroscopy (MRS) in monitoring treatment response.

Main Methods:

  • RNA interference (RNAi) was used to down-regulate choline kinase expression in nonmalignant and malignant breast epithelial cell lines.
  • Proliferation and differentiation markers (PCNA, Ki-67, galectin-3, lipid droplets) were analyzed molecularly.
  • Magnetic resonance spectroscopy (MRS) was employed to assess choline phospholipid metabolism.

Main Results:

  • RNAi-mediated choline kinase knockdown significantly reduced cell proliferation.
  • Down-regulation of choline kinase promoted cell differentiation, evidenced by increased lipid droplet formation and galectin-3 expression.
  • Magnetic resonance spectroscopy (MRS) detected a significant reduction in phosphocholine levels, confirming the metabolic impact.

Conclusions:

  • Targeting choline kinase with RNAi is a promising strategy for breast cancer therapy.
  • Noninvasive MRS can effectively detect and evaluate the efficacy of choline kinase-targeted treatments.

More Related Videos

An In Vitro Dormancy Model of Estrogen-sensitive Breast Cancer in the Bone Marrow: A Tool for Molecular Mechanism Studies and Hypothesis Generation08:48

An In Vitro Dormancy Model of Estrogen-sensitive Breast Cancer in the Bone Marrow: A Tool for Molecular Mechanism Studies and Hypothesis Generation

Published on: June 30, 2015

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...